Updates are available Correction dated 2022-10-20
Click to view Correction: https://doi.org/10.1038/s41420-022-01223-x
-
Authors
Oh, Soo-Jin https://orcid.org/0000-0001-9267-2039
Ikeda, Masataka https://orcid.org/0000-0003-1893-8171
Ide, Tomomi
Hur, Kyu Yeon
Lee, Myung-Shik https://orcid.org/0000-0003-3292-1720
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (NRF-2019R1A2C3002924, 2017M3A9G7073521)
Korea Drug Development Fund (HN22C0278)
Soonchunhyang University (20220346)
- License Information
-
More Information
Article History
Received: 3 May 2022
Revised: 15 September 2022
Accepted: 22 September 2022
First Online: 8 October 2022
Change Date: 20 October 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41420-022-01223-x
Competing interests
: M-SL in the CEO of LysoTech, Inc. All authors declare no competing interests.
